Clinical Trial Update: Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the efficacy of pamidronate in treating bone loss observed in liver transplant recipients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Osteodystrophy
• Osteopenia
• Osteoporosis

Drugs mentioned

• Aredia (pamidronate disodium) (pamidronate disodium)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Bone Disease, Metabolic | Phase 4 | Status: COMPLETED